Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, Suzuki T, Okumura N, Iwasaki H, Terada J, Ainai A, Sakai Y, Park E, Seki S, Akazawa D, Shimojima M, Shiwa-Sudo N, Virhuez-Mendoza M, Miyauchi K, Moriyama S, Iwata-Yoshikawa N, Harada M, Harada S, Hishiki T, Kotaki R, Matsumura T, Miyamoto S, Kanno T, Isogawa M, Watashi K, Nagata N, Ebihara H, Takahashi Y, Maeda K, Matano T, Wakita T, Suzuki T, Sugiura W, Ohmagari N, Ujiie M. Morino E, et al. Among authors: tomita n. NEJM Evid. 2024 Mar;3(3):EVIDoa2300290. doi: 10.1056/EVIDoa2300290. Epub 2024 Feb 27. NEJM Evid. 2024. PMID: 38411447
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M, Ashida S, Morioka S, Satake M, Hangaishi A, Togano T, Shiratori K, Takamatsu Y, Maeda K, Ohmagari N, Sugiura W, Mitsuya H. Tomita N, et al. Life (Basel). 2022 Jun 8;12(6):856. doi: 10.3390/life12060856. Life (Basel). 2022. PMID: 35743887 Free PMC article.
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.
Terada-Hirashima J, Takamatsu Y, Shimizu Y, Uemura Y, Takeuchi JS, Tomita N, Matsuda K, Maeda K, Yamamoto S, Fukunaga A, Ohmagari N, Mikami A, Sonoda K, Ujiie M, Mitsuya H, Sugiura W. Terada-Hirashima J, et al. Among authors: tomita n. Hum Vaccin Immunother. 2023 Dec 31;19(1):2193074. doi: 10.1080/21645515.2023.2193074. Epub 2023 Apr 13. Hum Vaccin Immunother. 2023. PMID: 37052247 Free PMC article. Clinical Trial.
Potential availability of saliva-based reverse transcription-quantitative polymerase chain reaction in extensive screening for asymptomatic individuals as a business continuity strategy during the coronavirus disease 2019 pandemic.
Tomita N, Kimura M, Uemura Y, Kazuyama Y, Ikeda M, Sugiura W. Tomita N, et al. Respir Med Res. 2024 Jun;85:101085. doi: 10.1016/j.resmer.2024.101085. Epub 2024 Jan 14. Respir Med Res. 2024. PMID: 38657293 No abstract available.
1,139 results